Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 8 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026, Mar 2026, Apr 2026, May 2026, Jun 2026, Jul 2026, Aug 2026 and Sep 2026.
- Largest single sale: $1.4M (40,000 shares) of Enliven Therapeutics, Inc. on Mar 25, 2026. Filing
- Last sale before this period: Oct 18, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | Chief Medical Officer | Feb 27, 2023 | Sep 21, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 17, 2026, Enliven Therapeutics, Inc.: sold 5,000 shares for $252K, under a disclosed plan; 5,000 shares acquired by exercising options. 1 filing: 1
- Aug 17, 2026, Enliven Therapeutics, Inc.: sold 5,000 shares for $293K, under a disclosed plan; 5,000 shares acquired by exercising options. 1 filing: 1
- Jul 17, 2026, Enliven Therapeutics, Inc.: sold 5,000 shares for $263K, under a disclosed plan; 5,000 shares acquired by exercising options. 1 filing: 1
- Jun 17, 2026, Enliven Therapeutics, Inc.: sold 5,000 shares for $219K, under a disclosed plan; 5,000 shares acquired by exercising options. 1 filing: 1
- May 18, 2026, Enliven Therapeutics, Inc.: sold 5,000 shares for $199K, under a disclosed plan; 5,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.